Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check2 days agoChange DetectedA banner announces NIH website changes and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.7%

- Check8 days agoChange DetectedThe website footer revision changed from v3.7.1 to v3.7.2; the study record content appears unchanged.SummaryDifference0.1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded the revision entry Revision: v3.7.0 to the Record History and removed Revision: v3.6.6, updating the page's version history to reflect the latest update.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry labeled v3.6.6 has been added to the record history. The previous v3.6.5 entry has been removed.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry, v3.6.5, was added to the study's record history. The previous revision, v3.6.4, was removed from the current history list.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.